The study of probiotic supplementation for prophylaxis of infectious disorder including acute colitis in hematological malignancies

The study of probiotic supplementation for prophylaxis of infectious disorder including acute colitis in hematological malignancies - Probiotic supplementation for prophylaxis of infectious disorder in hematological malignancies

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029440

Enrollment

Registered

2017-10-06

Start date

2017-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute leukemia

Interventions

Intervention/Through-out of anti-cancer treatment Control group with no suppelementation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Tha cases of acute myeloid or lymphoid leukemia undergoing induction or consolidation chemotherapy

Exclusion criteria

Exclusion criteria: Nothing paticular

Design outcomes

Primary

Measure	Time frame
1)The frequencies or severity of gastrointestinal complication and febrile neutropenia 2)The frequencies or severity of bacterial colitis and sepsis	—

Secondary

Measure	Time frame
The effect of probiotics supplementation in comparison with historical control	—

Countries

Japan

Contacts

Public ContactMasao Hagihara

Eiju General Hospital Division of Hematology

hagihara@eijuhp.com0338338381

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026